MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2.
第一作者:
Faqing,Tian
第一单位:
Department of Hematology, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, P.R. China.
作者:
主题词
老年人(Aged);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);细胞周期(Cell Cycle);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);男(雄)性(Male);微RNAs(MicroRNAs);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);RNA干扰(RNA Interference)
DOI
10.3892/ijmm.2018.4019
PMID
30535471
发布时间
2019-05-20
- 浏览17
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文